Subtype
Malignant Large Intestinal Neoplasm
CI-CAN-00003173Explore in graph →
1,624 active trials21 approved drugs383 evidence items
- NCIt
- C215202
Loading cancer entity…
Subtype
CI-CAN-00003173Explore in graph →
Clinical trials
7,504 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (742)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04863768 | Molecular Profiling of Colorectal Cancer | unknown | — | 300 | Hellenic Cooperative Oncology GroupOTHER | 1 | Apr 28, 2021 | clinicaltrials |
| NCT04495387 | Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy | unknown | — | 100 | University of FlorenceOTHER | 0 | Apr 27, 2021 | clinicaltrials |
| NCT04850027 | MRI-guided Lateral Lymph Node Dissection in Rectal Cancer | unknown | — | 268 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 26, 2021 | clinicaltrials |
| NCT02167321 | Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision | unknown | Phase 2 | 90 | Yonsei UniversityOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT03286738 | Pattern of Use of Bevacizumab or Cetuximab + FOLFIRI Regimen as First-line Treatment in Metastatic Colorectal Cancer | unknown | — | 1,800 | Joong Bae AhnOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT04852250 | Centralized Tumour Board and Secondary Intervention Rate in mCRC | unknown | — | 130 | Ludwig-Maximilians - University of MunichOTHER | 0 | Apr 21, 2021 | clinicaltrials |
| NCT04853784 | Prospective Registration Study of Totally Laparoscopy Versus Laparoscopy Assisted Colon Cancer Surgery(STARS-CC01) | unknown | — | 650 | The First Hospital of Jilin UniversityOTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT04851054 | Postoperative VEGF and Recurrence After Colon Cancer Surgery | unknown | — | 280 | Hospital del MarOTHER | 0 | Apr 20, 2021 | clinicaltrials |
| NCT04848311 | Indocanine Green as Tracer for Lymph Nodes Dissection in Station 253 | unknown | N/A | 66 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT04843189 | Prospective Registration Study of Robtic Laparoscopy Versus Laparoscopy Assisted Colon Cancer Surgery(STARS-CC02) | unknown | — | 648 | The First Hospital of Jilin UniversityOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT04838496 | Induction Chemotherapy for Locally Advanced Rectal Cancer(MEND-IT) | unknown | Phase 2 | 128 | Catharina Ziekenhuis EindhovenOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT04823793 | Fecal DNA Methylation Test for Colorectal Cancer Screening | unknown | — | 80 | Tri-Service General Hospital (TSGH)OTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT04833036 | c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI | unknown | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT04831528 | Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study | unknown | — | 100 | Fudan UniversityOTHER | 0 | Apr 5, 2021 | clinicaltrials |
| NCT02752698 | Domestic Surgical Robot Clinical Study | unknown | N/A | 200 | The Third Xiangya Hospital of Central South UniversityOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04819516 | Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal Cancer | unknown | Phase 1 | 10 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 29, 2021 | clinicaltrials |
| NCT04816045 | Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial | unknown | Phase 1 / Phase 2 | 24 | Zealand University HospitalOTHER | 0 | Mar 25, 2021 | clinicaltrials |
| NCT04814784 | Role of Neoadjuvent Radiotherapy in Locally Advanced Cancer Rectum | unknown | — | 48 | Amany sayed AbassOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT04423965 | A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC | unknown | Phase 2 | 220 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT04707482 | Mechanism and Process Regulation for Colorectal Tumors | unknown | — | 250 | Shanghai Minimally Invasive Surgery CenterOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT04714814 | Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis | unknown | — | 200 | Shanghai Minimally Invasive Surgery CenterOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT04801511 | Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer(CORT) | unknown | Phase 2 | 60 | Zhou FuxiangOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT03329664 | Autologous Killer Cell Therapy in Colon Cancer Patients | unknown | Phase 1 / Phase 2 | 20 | Sabz BiomedicalsINDUSTRY | 1 | Mar 15, 2021 | clinicaltrials |
| NCT04788381 | The Effects of Preoperative Bevacizumab on Perioperative Complications | unknown | — | 100 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT04773626 | Tumor Deposits in Cancer Colon | unknown | — | 100 | Assiut UniversityOTHER | 0 | Mar 5, 2021 | clinicaltrials |
| NCT04562727 | Microwave Ablation Combined With Chemotherapy for Colorectal Liver Metastases: a Multicenter Cohort Study | unknown | N/A | 668 | Ping LiangOTHER | 0 | Mar 4, 2021 | clinicaltrials |
| NCT04775862 | A Prospective Study Utilizing Circulating Cell Free DNA (cfDNA) Use in the Detection of RAS Mutations in Patients With Advanced Colorectal Cancer. | unknown | Phase 2 | 60 | National Guard Health AffairsOTHER_GOV | 1 | Mar 1, 2021 | clinicaltrials |
| NCT04773769 | Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas | unknown | N/A | 54 | Auxilio Mutuo Cancer CenterOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04771715 | Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer | unknown | — | 100 | Peking Union Medical College HospitalOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT04747951 | Total Neoadjuvant Therapy in Rectal Cancer Treatment | unknown | Phase 4 | 280 | State Scientific Centre of Coloproctology, Russian FederationOTHER_GOV | 1 | Feb 15, 2021 | clinicaltrials |
| NCT04752930 | ctDNA as a Assisted Diagnosis, Early Intervention and Prognostic Marker for Peritoneal Metastases From Colorectal Cancer | unknown | N/A | 138 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT04749381 | The Role of TCM on ERAS of Rectal Cancer Patients(RCT) | unknown | Phase 2 | 264 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 11, 2021 | clinicaltrials |
| NCT04751149 | Incidence of Acute Urine Retention: Randomized Clinical Trial Comparing Early, Mid or Late Urinary Catheter Removal in Patients With Rectal Resection(RAOREC) | unknown | N/A | 143 | Hospital DonostiaOTHER | 1 | Feb 11, 2021 | clinicaltrials |
| NCT03977090 | Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer | unknown | Phase 1 | 21 | Genor Biopharma Co., Ltd.INDUSTRY | 1 | Feb 10, 2021 | clinicaltrials |
| NCT04162535 | Elucidation of the Mechanisms and Effects of Certain Anesthetic Interventions on Digestive Cancer Patients Subjected to Surgery | unknown | Phase 1 | 40 | Iuliu Hatieganu University of Medicine and PharmacyOTHER | 1 | Feb 10, 2021 | clinicaltrials |
| NCT04103697 | Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer(RuCorT-01) | unknown | Phase 3 | 560 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04134897 | Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer(RuCorT-02) | unknown | Phase 3 | 316 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04135313 | Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer(RuCorT-03) | unknown | Phase 3 | 540 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04745091 | MRI Split Scar Sign as a Predictor to Complete Pathologic Response After Neoadjuvant Chemoradiation in Rectal Cancer | unknown | — | 20 | Alexandria UniversityOTHER | 0 | Feb 9, 2021 | clinicaltrials |
| NCT02972541 | Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer(NACSOC) | unknown | N/A | 248 | Beijing Chao Yang HospitalOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT04051450 | Immune Checkpoints in Colorectal Cancer | unknown | — | 68 | Chinese University of Hong KongOTHER | 1 | Feb 5, 2021 | clinicaltrials |
| NCT04717947 | Interval Between Neoadjuvant Therapy and Surgery in the Treatment of Locally Advanced Rectal Cancer (CRONOS)(CRONOS) | unknown | — | 911 | Hospital Clinic of BarcelonaOTHER | 1 | Feb 4, 2021 | clinicaltrials |
| NCT04738214 | Development of a Genome-based Platform for Personalized Treatment in Locally Advanced Rectal Cancer Patients | unknown | — | 39 | Yonsei UniversityOTHER | 1 | Feb 4, 2021 | clinicaltrials |
| NCT03620877 | A Program for Improved Family Screening for Colorectal Cancer(COLOR3) | unknown | N/A | 500 | Poitiers University HospitalOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT04735900 | lead-in FOLICOLOR Trial: Following Therapy Response Through Liquid Biopsy in Metastatic Colorectal Cancer Patients | unknown | N/A | 60 | University Hospital, AntwerpOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT04737213 | SGM-101 in Colorectal Lung Metastases(SGM-CLM) | unknown | Phase 2 | 10 | Leiden University Medical CenterOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT04508452 | A Phase II Prospective Trial of mXELOXIRI Reintroduction for mCRC | unknown | Phase 2 | 91 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Feb 2, 2021 | clinicaltrials |
| NCT04734249 | Second-line Surufatinib Combined With Chemotherapy in Advanced CRC | unknown | Phase 2 | 56 | Fujian Cancer HospitalOTHER_GOV | 0 | Feb 2, 2021 | clinicaltrials |
Data updated 24 days agoSource updated Apr 28, 2021source: clinicaltrials